CF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CF Industries is a good buy right now for a beginner focused on long-term investing with $50,000-$100,000 available. The stock has strong fundamental momentum, with Q1 2026 revenue up 19.42% YoY, net income up 97.12% YoY, EPS up 115.14% YoY, and gross margin expansion. The current analyst trend is constructive, with multiple firms raising price targets meaningfully. Even though short-term technical momentum is slightly weak, the broader setup remains favorable, and the stock is trading near a level that still offers a reasonable entry for a long-term buyer who is not waiting for a perfect pullback. Overall: buy.
Current price is 118.96, slightly above the previous close of 118.68, with pre-market weakness, a regular-session decline of 0.90%, and a small post-market rebound. Technically, the trend is still constructive because SMA_5 > SMA_20 > SMA_200, which is bullish. However, MACD histogram is -0.483 and negatively expanding, showing short-term momentum has softened. RSI_6 at 37.95 is neutral-to-weak but not oversold. Key levels to watch are support at 115.87 and resistance at 121.87; a move above pivot could improve momentum, while failure to hold above support would weaken the setup. The stock trend model also suggests near-term softness, but the long-term trend remains intact.
["Q1 2026 earnings were very strong, with net income up 97.12% YoY and EPS up 115.14% YoY.", "Revenue rose 19.42% YoY and gross margin improved 8.81% YoY.", "Nitrogen pricing remains strong due to Middle East supply disruptions and tighter global fertilizer markets.", "Analysts have broadly raised price targets over the past month, with Barclays, UBS, Goldman Sachs, RBC, CIBC, and Morgan Stanley all turning more constructive on valuation and earnings potential.", "Hedge funds are buying, with buying amount up 325% over the last quarter.", "Call activity is stronger than put activity, supporting bullish trading sentiment."]
["MACD is negative and weakening, suggesting short-term momentum loss.", "RSI is not strong, indicating the stock is not in a high-momentum breakout phase.", "Insiders are selling, with selling amount up 190.48% over the last month.", "A facility outage reduced sales volumes in the latest quarter.", "The stock trend model suggests negative near-term performance over the next day, week, and month.", "There is no recent congress trading data to support a politically driven catalyst."]
Latest quarter: Q1 2026. Financials were strong across the board. Revenue increased to $1.986 billion, up 19.42% YoY. Net income rose to $615 million, up 97.12% YoY. EPS increased to $3.98, up 115.14% YoY. Gross margin improved to 37.56%, up 8.81% YoY. These results show robust profitability and strong operating leverage in a favorable nitrogen pricing environment.
Analyst sentiment has improved recently. Barclays raised its target to $145 and keeps an Overweight rating, Goldman Sachs raised target to $132 and keeps Neutral, UBS raised target to $140 and keeps Neutral, RBC raised to $125 and keeps Sector Perform, CIBC raised to $128 and keeps Neutral, and Scotiabank raised to $115 and keeps Sector Perform. The overall Wall Street view is mixed but increasingly positive on price targets, with the bullish side emphasizing nitrogen pricing strength and free cash flow. The cautious side argues the stock is fairly valued and some of the supply shock upside may already be priced in. Net takeaway: pros are leaning constructive, while cons remain centered on valuation and the sustainability of the catalyst.
